Additionally, intraperitoneal administration of ASO targeting lncRNA DNM3OS, a regulator of the TGF-β pathway, attenuated bleomycin-induced lung fibrosis in mice (104). This evidence concerns the gene TGFB1 and pulmonary fibrosis.